Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 2,123.30
-13.40 (-0.63%)
At close: Mar 2, 2026
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 602.98 billion as of March 2, 2026. Its market cap has increased by 38.74% in one year.
Market Cap
602.98B
Enterprise Value
588.32B
Revenue
165.10B
Ranking
n/a
PE Ratio
56.61
Stock Price
2,123.30
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 602.98B, an increase of 52,364.70%. That is a compound annual growth rate of 28.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 602.98B | 4.99% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cipla | 1.09T |
| Mankind Pharma | 927.82B |
| Zydus Lifesciences | 927.45B |
| Aurobindo Pharma | 708.81B |
| Alkem Laboratories | 674.29B |
| Laurus Labs | 580.78B |
| Ipca Laboratories | 387.89B |
| Ajanta Pharma | 373.90B |